Personalized immunotherapy selection for breast cancer
Share:
Tech ID:
17-046
Principal Investigator:
Professor Qing-Xiang Amy Sang and Professor Jinfeng Zhang
Licensing Manager:
Patents:
- Patent Pending
Description:
Professors Sang and Zhang have identified biomarkers that define subgroups of breast cancer and clinically useful classifiers for distinguishing breast cancer subtypes. The present invention provides methods for selecting a therapy for a patient suffering from breast cancer based on expression levels of biomarkers. The present invention also provides methods for treating breast cancer.
